Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iRhythm Technologies, Inc. - Common Stock (NQ:IRTC)

187.30 +3.18 (+1.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iRhythm Technologies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
iRhythm Well-Positioned For 2026 After Upbeat Results And Raised Outlook
iRhythm Technologies beat Q3 estimates with record revenue, raised its 2025 sales outlook, and gained analyst confidence with higher price targets. 
Via Benzinga
Why iRhythm (IRTC) Stock Is Trading Up Today
Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 3.2% in the afternoon session after it reported strong third-quarter financial results that surpassed expectations and... 
Via StockStory
Topics Artificial Intelligence World Trade
IRTC Q3 Deep Dive: New Account Growth and AI Partnerships Fuel Guidance Raise
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s... 
Via StockStory
Topics Artificial Intelligence
Earnings Scheduled For October 30, 2025
 
Via Benzinga
How Is The Market Feeling About iRhythm Technologies?
 
Via Benzinga
Where iRhythm Technologies Stands With Analysts
 
Via Benzinga
iRhythm Technologies Inc (NASDAQ:IRTC) Surpasses Q3 Expectations and Raises 2025 Outlook
iRhythm stock surges after Q3 earnings crush estimates. Revenue jumps 30.7% and the company narrows its loss, raising its full-year outlook. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
 
Via Benzinga
iRhythm (NASDAQ:IRTC) Beats Expectations in Strong Q3, Stock Soars
Medical technology company iRhythm Technologies (NASDAQ:IRTC) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 30.7% year on year to $192.9 million. The company’s full-year revenue... 
Via StockStory
iRhythm Earnings: What To Look For From IRTC
Medical technology company iRhythm Technologies (NASDAQ:IRTC) will be announcing earnings results this Thursday after market close. Here’s what you need to know. 
Via StockStory
3 Unprofitable Stocks We Find Risky
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
Forecasting The Future: 14 Analyst Projections For iRhythm Technologies
 
Via Benzinga
Tesla To $300? Here Are 10 Top Analyst Forecasts For Monday
 
Via Benzinga
What's Driving the Market Sentiment Around iRhythm Technologies Inc?
 
Via Benzinga
Q2 Earnings Recap: iRhythm (NASDAQ:IRTC) Tops Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers. 
Via StockStory
Topics Artificial Intelligence
2 Healthcare Stocks to Research Further and 1 Facing Challenges
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. 
Via StockStory
Topics Government World Trade
IRHYTHM TECHNOLOGIES INC (NASDAQ:IRTC) Combines Technical Strength and Growth Momentum
IRTC stock combines strong technical trends with accelerating fundamentals, aligning with Mark Minervini's high-growth strategy for potential continued gains. 
Via Chartmill
1 Cash-Producing Stock with Competitive Advantages and 2 We Question
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak... 
Via StockStory
Expert Outlook: iRhythm Technologies Through The Eyes Of 9 Analysts
 
Via Benzinga
1 Growth Stock to Add to Your Roster and 2 We Brush Off
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
3 Overrated Stocks with Open Questions
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
3 Unprofitable Stocks We Steer Clear Of
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday
 
Via Benzinga
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies
Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product safety issues. 
Via Benzinga
Alignment Healthcare, Bio-Techne, Envista, iRhythm, and UFP Technologies Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer... 
Via StockStory
Topics Economy
IRTC Q2 Deep Dive: Core Business Momentum and Product Expansion Shape Outlook
Medical technology company iRhythm Technologies (NASDAQ:IRTC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 26.1% year on year to $186.7 million. The company’s... 
Via StockStory
Topics Artificial Intelligence Economy
Tandem Diabetes, iRhythm, agilon health, Fortrea, and 10x Genomics Shares Skyrocket and Plummet, What You Need To Know
A number of stocks traded in opposite directions in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index... 
Via StockStory
Topics Bonds Economy Stocks
3 Unpopular Stocks We Find Risky
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Topics Economy
iRhythm Technologies Inc (NASDAQ:IRTC) Fits Mark Minervini’s Trend-Following Strategy with Strong Technicals and Growth Momentum
iRhythm Technologies (IRTC) aligns with Mark Minervini's trend-following strategy, showing strong technicals, rising revenue, and earnings growth. A top performer in healthcare, IRTC is near its... 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.